The PHenomenal project has launched a new video to raise awareness for pulmonary hypertension, a respiratory disease for which there is currently no cure. The project was created by the Pulmonary Hypertension Association (PHA) and SteadyMed to celebrate everyone who is dealing with pulmonary hypertension. In this…
Actelion recently announced that its oral drug Uptravi (selexipag) is now commercially available in Germany for the treatment of pulmonary arterial hypertension (PAH). “The availability of Uptravi is a milestone for PAH patients in Germany, where until now, the options for treatments targeting the prostacyclin pathway have been limited, and were burdensome…
Steve Van Wormer and Lucas Van Wormer are now among the most prominent faces in the fight against pulmonary hypertension (PH). But who are they? The story of this family is intrinsically marked by an unimaginable turn, the global movement #PHAware, and the chronic disease that is characterized by high…
Everyone text ‘MADZ95 £3’ to 70070 to donate £3 towards the Pulmonary Hypertension Association and #poutforPHA (2/2) pic.twitter.com/6Xh9Jx7Ozb — Abbie Mattingley (@AbbieMattsPR) 18 de abril de 2016 Maddy Hardman was a 20-year-old with pulmonary hypertension (PH) who died unexpectedly…
https://www.youtube.com/watch?v=apwrg0fyx70 Pulmonary hypertension affects different aspects of a patient’s life, mainly due to symptoms such as shortness of breath, fatigue, dizziness or fainting spells, chest pressure or pain, swelling (edema) in the ankles, legs and eventually abdomen (ascites), cyanosis, and racing pulse or heart palpitations. But how is pulmonary…
Galectin Therapeutics recently announced that GR-MD-02, its galectin-3 (gal-3) inhibitor in development-stage, has shown a positive effect on vascular remodeling in an animal model of pulmonary arterial hypertension (PAH). Galectin proteins are key mediators of biologic function. The announcement was made during a poster presentation of the company’s preclinical results at…
Understanding pulmonary diseases is often difficult, even for patients or loved ones of those who suffer from the condition. In this video, the breathing process and why it is necessary for the body is explained, as well as details about the different types of problems that may occur in…
The Pulmonary Hypertension Association (PHA) is the world’s oldest and currently the largest organization of its kind focused on fighting pulmonary hypertension (PH). But talking about the work of the organization or how it was born is not possible without first telling the story of the four women who met…
Chloe Temtchine is a celebrity and singer like many others, but she is also a pulmonary hypertension (PH) patient who uses her talent to raise awareness for the disease. The breathing tubes that the singer needs to use while singing became her mark, while her music became an inspiration for patients…
https://www.youtube.com/watch?v=5KX_0biPgmQ Pulmonary hypertension (PH) is a disease characterized by high blood pressure in the arteries of the lungs and right side of the heart. Patients often experience symptoms such as shortness of breath (dyspnea), fatigue, dizziness or fainting spells (syncope), chest pressure or pain, swelling (edema) in the ankles, legs and…
Several Broadway popular performers will focus their attention on pulmonary hypertension (PH) at the Second Annual “Breathless on Broadway” benefit on June 6 at Sardi’s Restaurant in New York City. Some of Broadway’s favorites will help the Phware Global Association raise awareness about the disease. The event will include a…
Reviva Pharmaceuticals, Inc. recently presented positive preclinical efficacy results for RP5063 in pulmonary arterial hypertension (PAH) at the American Thoracic Society (ATS) 2016 International Conference, held in San Francisco from May 13-18. RP5063 is a novel atypical antipsychotic drug with a relatively unique pharmacology and a novel target for treating PAH. Its…
Get regular updates to your inbox.